Raghuram Selvaraju

Raghuram Selvaraju is a research analyst at H.C. Wainwright who focuses on biopharmaceutical companies. He recently initiated coverage of Alpha Cognition Inc., praising its lead product ZUNVEYL for its potential to improve treatment for neurodegenerative disorders and its favorable safety profile compared to existing therapies.